Turku, Finland

Ida Erling



 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ida Erling: Innovator in Sample Detection Technology

Introduction

Ida Erling is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of sample detection technology, particularly in the context of neonatal screening. With a total of 2 patents to her name, her work has the potential to enhance the reliability of medical testing processes.

Latest Patents

Ida's latest patents focus on a method and apparatus for detecting the elution of samples. This invention relates to a technique for detecting the elution of a sample from a sample substrate to an incubation buffer contained in a sample well while the sample substrate remains within the well. The method involves measuring light absorption of the contents of the sample well at a predefined wavelength or wavelength range. Based on the absorption measurement, the degree of elution of the sample can be determined. The invention utilizes a wavelength or wavelength range that is absorbed by at least one elutable component of the sample but transmitted by the sample substrate. This innovative approach provides a reliable means of determining the degree of elution of blood samples, particularly in neonatal screening applications.

Career Highlights

Ida Erling is currently associated with Wallac Oy, a company known for its advancements in medical technology. Her work at Wallac Oy has allowed her to focus on developing innovative solutions that improve sample detection methods.

Collaborations

Ida collaborates with her coworker, Raimo Harju, to further enhance the research and development of their projects. Their teamwork exemplifies the importance of collaboration in driving innovation.

Conclusion

Ida Erling's contributions to sample detection technology are noteworthy and have the potential to significantly impact neonatal screening processes. Her innovative methods and dedication to improving medical testing will continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…